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SUMMARY.-A retrospective detailed study of 272 cases of breast carcinoma
treated by radical mastectomy was published by Hamlin (1968). An extended
analysis of the material for 258 of these cases is now reported.
Data for21 prognostic factors from258patients havebeensubjected tomultiple
regression analysis to determine the independent effect and thus the relative
importance of each factor. Thefindings confirmprevious single factoranalyses
and demonstrate that nine of the factors are independently associated with
survival.
Mathematical manipulation of the information obtained in this analysis
allowed a risk score to be allotted to each patient. Grouping of patients by the
prediction scores is found in this series to be more closely related to survival
than is clinical staging of the same patients.
THE large number and variety of papers published on carcinoma of the breast,
the treatment, prognosis and associated factors, are an index of the complexity of
the problem and indeed of the study of any tumour. Because this is a relatively,
common lesion, studies of many aspects have been possible. As a rule one aspect
in particular has been examined and a relationship to prognosis or aetiology has
been revealed. However, the importance of a particular factor and its indepen-
dence of, or dependence upon, other factors can onlv be assessed if many factors
in one group ofpatients are assessed and analysed.
Factors which have been shown to influence the prognosis in carcinoma of the
breast in the female include the following: age (McKenzie, 1955), menopausal
status (MacMahon, List and Eisenberg, 1968), size of tumour (McWhirter, 1957),
delay (Registrar General, 1967), clinical stage (Paterson, Tod and Russell, 1939),
axillary node involvement (Myers, Axtell and Zelen, 1966), size of axillary nodes
(Fisher, Slack and Bross, 1969), internal mammary node involvement (Handley
and Thackray, 1954), malignancy grading of tumour (Bloom, 1950), host response
(Hamlin, 1968), hormone balance (Hayward, Bulbrook and Greenwood, 1961),
serum cholesterol levels (Juret, Aubert and de Kaou6l, 1967), treatment (Bloom,
Richardson and Harries, 1962).
It is clear from this list that many of these factors are interdependent. Age
and menopausal status are related and both are probably related to hormone
balance and perhaps to serum cholesterol levels. The size of the tumour, the
delay in seeking advice, the clinical stage, and the node involvement are almost
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certainly reflections of a balance between the malignancy grading of the tumour
and the host defence response.
However, information about a tumour and the host is, in the last analysis,
only ofvalue ifthis information can be of use toguide the clinician in thediagnosis
and treatment of the individual patient. In carcinoma of the breast, it is the
treatment of the patient which is currently under examination and discussion.
The efficacy of any particular treatment can only be assessed if the influence of
pre-treatment clinical and pathological factors are know-n. Various forms of
treatment can be compared if all the pretreatment factors known to influence
the prognosis are measured and their influence is allowed for.
The factors mentioned above do not provide a complete list; there are others
which may be relevant, and future work will no doubt add to the list (as well as
excluding some of those mentioned). With this number of variates to be con-
sidered in an examination ofthe determinants ofsurvival, theproblem is complex;
a planned study requires large numbers of patients from whom a wide range of
information must be collected. The wealth of data from such a study will be
rather confusing and far removed from classic scientific experiment where one
alters one factor at a time in order to identify the action of cause and effect.
Myers, Axtell and Zelen (1966) have drawn attention to this problem, and suggest
that a special analysis is required to study simultaneously the effect of several
variates. The technique that they used only enabled them to use data from four
variates at one time; this falls far short of the requirements in breast cancer.
Material is nowreported for 21 ofthe relevantindependent variates; this has been
analysed in a way which attempts to disentangle theindependent effects that each
factor exerts on survival.
MATERIAL
In a previous paper, Hamlin (1968) presented evidence supporting the hypo-
thesis that the prognosis of a patient with carcinoma of the breast is dependent
on the host reaction to the tumour as well as the grade of malignancy of the
tumour. Thematerialwasderivedfrom272patientstreatedattheRoyalMarsden
Hospital by radical mastectomy between 1935 and 1945, who either died from
their carcinoma, or were alive 15 years or more after initial treatment. In the
original analysis a large number of factors were assessed, but in the final analysis
and in the present multivariate analysis, the following 21 factors were used.
DEFINITION OF FACTORS
Clinical stage.-The original hos ital records were examined by a single
observer (M.D.S.); from an evaluation of the clinical facts each case was staged
according to the TNM system. Clinical size was present for only 137 of the 258
patients; the staging has therefore had to be done without reliance on tumour size.
Duration ofsymptoms.-The duration ofsymptoms in months preceding initial
hospital treatment.
Age.-The age ofthe patient recorded at the time ofinitial hospital treatment.
Menopausal status.-Menopausal status recorded at time of initial hospital
treatment. For women for whom this information was not present in the notes,
those aged 45-49 were grouped with menopausal women; those outside this age
range were grouped with pre- and post-menopausal women.
Marital status.-Marital status recorded at time of initial hospital treatment.
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Site.-The site of the primary recorded in the clinical notes before treatment
(the following six sites were used: upper inner, lower inner, upper outer, lower
outer, central and axillary).
Laterality.-Origin ofprimary in left or right breast.
Pathological size.-The size in centimetres as recorded at the pathological
examination of the primary. For a number of specimens no measurement had
been made but it was possible in most cases to assess the size of the tumour from
the histological preparations available for study.
Axillary node involvement.-Axillary nodes were recorded as positive or nega-
tive, without comment as to which or how many nodes contained metastases or
whether a single node contained just one peripheral metastasis or was completely
replaced.
Malignancy grading.-As in Hamlin (1968), the malignancy grading used was
a modification of that described by Bloom (1950) with division of patients into
well differentiated tumours (approximately equivalent to Bloom Grade 1) and the
rest (equivalent to Bloom Grades 11 and III).
Shape of the edge of the tumour.-Careinomas of the breast vary considerably
in the shape of the infiltrating edge of the tumour, but essentially can be divided
into three groups: a
" round
" edge, a serrated edge and a third group where no
true edge is present, the tumour cells infiltrating as cords of single cells over a
large ill-defined area.
Stroma o the tumour.-Here the word stroma applies to the supporting tissue
of the tumour which is either loose and vascular with little collagen present in it
(as in the "medullary
" carcinoma), or is densely collagenous (as in the
" scirr-
hous
" carcinoma), or is a mixture ofthese two. In theoriginalanalysis a number
of groups were recognised but were finally amalgamated to form two groups
givingthepredominantpicture of either
" loose fibrovascular
" or
"collagenous
Host defence reactionfactors.-(See Hamlin (I968) for details.)
(i) Lymphocy-tic and plasmacytic infiltration around the tumour.
(ii) Lymphocytic and plasmacytic infiltration within the tumour.
(iii) Thenumber, size andactivity ofthegerminal centres intheaxillarynodes.
(iv) The immunoblast content of the cortex of the axillary nodes.
(v) The plasma cell content of the axillary nodes.
(vi) The sum of these five.
Sinus histiocytosis of axillary nodes, as defined by Black and Speer (1958).
This was scored as 0, +, ++, and +++ in the original analysis (Hamlin, 1968)
and was used in the present analysis in this form.
Mast cell infiltration of the edge of the tumour.-This was scored as 0, +
+++ in the original analysis.
Year of treatment.-Year in which radical mastectomy was performed.
Radiotherapy.-This was recorded as immediate post-operative irradiation
given or not given. All cases receivingpreoperativeradiotherapy were excluded.
STATISTICAL METHOD
Hamlin (1968) discussed the relationship of host defence response to tumour
grading, clinicalstaging, nodal metastasis, age and menopausal status. The main
emphasis was on the relationship between host defence response and survival.
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survival was provided by class of host defence reaction within a particular malig-
nancy grade. In a complex multifactorial situation the examination of sub-
groups of the data is one method of trvin-a to identify evidence of a direct, inde-
pendent effect of a particular factor on survival. This approach has a major
disadvantage as it involves splitting the data into smaller and smaller numbers;
interpretation thus becomes difficult due to the diminished weight that can be
placed upon such small numbers. An alternative statistical analysis of this
material is now presented.
There is avariety ofstatisticaltechniques suitable forinvestigation ofthe class
of problem posed here where the effect of a range of prognostic factors on a
particular outcome is to be examined. InitiaRy one can examine the direct
association between each ofthe factors and outcome, and also the extent to which
the
" independent
" factors are inter-related. A multivariate analysis can then
be applied which hasthreeadvantages. First it enables one to examine the enti-re
set of data and quantify in a relatively simple form the independent contribution
that each of the factors makes to outcome. The computer programme used for
this, of course, does not appreciate the natural history of breast cancer and arbi-
trarily divides overlapping associations in order to identify the independent
contributions, but it certainly provides one method of disentangling the multi-
factorial determinants ofsurvival. This may aid theunderstanding ofthe natural
history of the disease. Secondly, where a number of factors have been recorded
which involve time-consuming investigation, multiple regression analysis may
demonstrate the part that each of these factors plays in predicting survival; this
may indicate how increasedweight may be placed upon certain ofthe items, thus
dispensing with the need in future studies to assess the remainder. Thirdly, the
analysis enables one to derive scores that can be used to classify the patients into
low and high risk. By virtue of its power to assess a wide range offactors, and
weight these in a consistent way, it may be possible to refine the accuracy of
prediction of outcome. With suitable safeguards, this statistical prediction may
be used in the consideration of alternative treatment strategies for individual
patients.
Linear multiple regression is applicable if one can assume that each of the
factors exerts a direct linear effect on theparticular outcome that isbeing studied,
and that for anyparticular value ofthepredictor factor the values for the outcome
arenormally distributed about a mean. The effect on survival ofthe factors listed
above has been examined. Survival was recorded in years and this could be
examined in relation to clinical stage scored as 1, 2 or 3; survival decreases from
stage to stage, and it can be assumed that the association is sufficiently close to a
linear one for the application of the multiple regression model. The size of the
tumour, the duration before initial treatment, the age ofthe patient and the year
of treatment were all quantitative items; the scores used were derived from
grouping the data. All the histological factors used have been scored on scales
such that each increment is presumed to be related to a change in survival. The
location of the primary lesion was allotted to one of six sites; the literature does
not provide clear cut information about the relationship of each of these sites to
survival. The material for the 258 patients was therefore examined and the sites
ranked in order of increasing mean survival. This rank, which is shown
Table 1, was used as the score for site in the next phase o'f the analysis.
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better prognosis for those women who are in the immediate premenopausal
interval andpossibly for those who are menopausal. Information about the prog-
nosis of the young and the old relative to the menopausal group is not well docu-
mented. In the absence of clear direction, two groups were formed; patients
stated to be menopausal with those in the immediate premenopausal interval and
the young premenopausal women with the post menopausal.
Five other items were included where there were only two alternative answers,
i.e. whether or not axillary nodes were involved on histological examination,
whether or not radiotherapy was given as part of initial treatment, whether the
lesion was in the right or left breast, whether the patient was married or not, and
whether the stroma was densely collagenous or loosely fibrovascular. Each of
these items has been given an arbitrary code to identify which of the two sub-
groups the patient falls into; the analysis used does not appear to be unduly
affected by the use of such dichotomies in the data. Complete information was
available for 159 patients; for an additional 99 subjects information was missing
formenopausal status. These were allocated a score according to age (see above).
TABLEL-Mean Survivalfor 258 Patients by Site of Breast Lesion
Number of Mean survival
Site patients in years Rank*
Central 39 5- 8 I
Upper inner 40 7
- 4 2
Lower outer 22 8-0 3
Lower iniier 22 8
- 7 4
Upper outer 129 10- 7 5
Axillary
. 6 11- 7 6
This rank was used in the multivariate analysis as the appropriate score for lesions in each of
the six sites.
The remaining 14 patients were excluded because one set of information was not
available. Thus the analysis of 21 factors was performed upon data from 258
patients treated by radical mastectomy.
RESULTS
The computer programme produced a correlation .natrix in which the correla-
tion between every possible pair of factors is provided; this gave an output with
a very large number of pairs of comparisons. This was extremely useful in
looking at the direct association between any of the factors and survival, and the
inter-relationship between each of the pairs of factors. Table 11 provides the
correlation coefficients for each of the factors against survival, i.e. a measure of
the overall association betweeneach factor andsurvival.t The factors have been
listed in the table in order of decreasing size of the correlation. The complete
correlation matrix has not beenprinted, but is available on request to the authors.
The multiple regression analysis of the data provides estimates of the inde-
pendent contribution of each of the factors to survival. These are given in
Table III in a modified form, being converted to the percentage of the total
t The correlation coefficient can vary between + I and -I; in this example + indicates that
survival increased with increasing score, whilst indicates that survival decreased with increasing
score. Aperfect linear association between any factor and survival would be indicated by a coefficient
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TABLEII.-Correlation Coefficient Between Each of 22 PrognO8tic Factor8
and Survivalfor 258 Patient8With BreadCancer
Clinical stage
Axillary node metastases
Size ofprimary
Stromal reaction
Radiotherapy given
Site ofprimary
Malignancy grading
Year of treatment
Host defence response*
Infiltration within the tumour
Menopausal status
-0-41
0-40
-0-35
-0- 32
0-28
0-23
-0- 21
0-21
0- 16
0.15
0- 14
Immunoblasts in axillary nodes
Infiltration around the tumour.
Laterality
Duration ofsymptoms
Plasma cell content in axillary nodes
Mast cell infiltration in tumour
Germinal centres in axillary nodes
Age
Sinus histiocytosis in axillary nodes
Edge of tumour
Marital status
0-12
0.11
0.09
0-09
0-08
0-08
0-07
-0-07
0-06
0-04
-0-02
If correlation coefficient > 0
- 12 or < 0
- 12 then P < 0
-05
>0-16 or <-0-16thenP<0-01
* Host defence response derived from combined score of five items; lymphocytic and plasmacytic infiltration around, and within the tumour; the number, size and activity of the germinal centres in
the axillary nodes; the immunoblast content of the axillary nodes; and the plasma cell content in the
axillary nodes.
TABLE III.-Percentage of Total Variance in SurvivalIndependently
Explained by Each of 22Prognostic Factorsfor 258 Patients With Breast Cancer
7
- 6
7
-0
6-4
3
- 6
3
- 5
3-4
3-4
3
-0
2
- 9
1
-4
1-3
1-1
0- 6
0-4
0-4
0-3
0-2
0-2
0.1
0.0
0.0
0.0
Axillary node metastases
Clinical stage
Size ofprimary
Radiotherapy given
Stromal reaction
Malignancy grading
Year treatment
Site ofprimary
Host defence responset
Infiltration around the tumour
Infiltration within the tumour
Menopausal status
Immunoblasts in axillary nodes
Sinus histiocytosis in axillary nodes
Duratio'n ofsymptoms
Mast cell infiltration in tumour
Laterability
Plasma cell content in axillary nodes
Age
Edge of tumour
Marital status
Germinal centres in axillary nodes.
If variance explained > 1
-5% P < 0
-05
>2-6% P<0.01
t See footnote to Table IL
TABLF, IV.-CoMpar?,8on of Observed Survival With (a) Clinical Stage, (b)
" Pre-
diction
" Score Based on all PrognO8tic Factors, for 151 Patients Sampled by
Years ofSurvival From 258 Women With Br'east Carcinoma
Obser-,.ed survival
t A
I year 5-10 years 15 years+ (a) Clinical stage
I
11 .
III .
(b) Prediction scorel
Low risk .
Intermediate
High risk .
1
3
22
0
6
20
7
10
17
5
19
10
36
32
23
59
27
5
tThis score was calculated for each patient by an application ofweights, derived from the multi-
variate analysis, to the actual patient data for each factor. The distribution of all the scores was
then arbitrarily divided into three groups, giving the above association between prediction score and
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variance in survival explained by each factor." Again the factors have been
listed in the table in descending order ofmagnitude.
Using data derived from the multivariate analysis it is possible to derive
prediction
" scores for eachpatient in the study, such that ahigh score indicates
likelihood oflong survival and a low score indicates short survival. These scores
are based on mathematical manipulation of the actual data recorded for each
patient in this study. The prediction scores used for Table IV are based on d4,ta
for all the factors, including histological study of the axillary nodes, and presents
a comparison between clinical staging and the prediction score as prognostic
instruments.
Table V shows the relationship between prediction score, derived from the
limited range of factors available when the operation performed has not included
removal of the axillary nodes, and survival.
TABLE V.-COMpart8on of Ob8erved Survival and (a) Clinical Stage, (b)
" Predic-
tion
" Score, Ba8ed on Restricted Li8t ofPrognO8tic Factor8,*for 151 Patient8
Sampled by Year8 ofSurvival From 258 Women With Bread Carcinoma
Observed survival
1 year 5w-10 years 15 years+
(a) Clinical stage
I 1 7 36
III 3 10 32
Ila 22 17 23
(b) Prediction scoret
Low risk 0 7 57
Intermediate 9 16 27
High risk 17 11 7
Patient's age, marital and menopausal status, duration of lesion; clinical stage and site; size of
primary, malignancy grading, lymphocytic and plasmacytic infiltration in and around the tumour,
stromal reaction. These items are available from history, clinical examination and histology of
primary lesion.
t See footnote to Table IV.
DISCUSSION OF RESULTS
Examination of data can be followed by presentation of the results in tables,
graphs and histograms. In a complex multifactorial situation, such as the study
ofprognosis in breast cancer, presentation ofresults in this way may oversimplify
the situation and lead to misinterpretation ofthe data. Thispaperreports a mo're
complex mathematical analysis of a set of data; this, however, brings with it
problems in thepresentation ofthe results. Anattempt has been made topresent
these in as simple a way as is possible in order that the reader may himselfiudae
the interpretation ofthe data.
Twenty-one separate prognostic factors were available for study in relation to
the observed survival for 258 patients -w-ith breast cancer; a twenty-second factor
t If the data for each patient correctly ranked each patient in order of actual survival, the sum of
the variance
" explained
" would be 100% ; if the data bore no relationship to survival, 0% would be
explained. In the data presented here, 44% of the variance in survival is explained on summing the
contributions of the 21 independent factors. The unexplained portion is due to a combination of
errors in the measurement ofthe factors included, other factors known to berelevant, but not included
in the study, unknown factors and chance. In biological problems such as this, it is unusual to
explain as high a percentage as in this study.653 PROGNOSTIC FACTORS IN BREAST CARCINOMA
was a score for host defence response obtainedby addition ofthe scores for five of
the factors (infiltration round tumour, infiltration in tumour, germinal centres,
immunoblasts, and plasma cell infiltration of the axillary nodes) (Table 11),.
Eight ofthe factors had a correlation coefficient with survival that was significant
at the I% level (i.e. P < 0-01). The one factor significant at this level that was
surprising was
" year of treatment "; all the patients had had initial surgery
between 1935 and 1945 and this finding suggests that the results of treatment
improved towards the end of the period.
The multivariate analysis carried out on the data enabled an estimate to be
made of the independent contribution that each of the factors made to survival;
such an analysis takes into account the degree of overlap between the factors
before defining the independent contribution that each factor makes towards
survival. Table III lists the factors in order of their independent contribution.
The same eight factors head the list and have predictive values significant at the
I% level; a ninth factor, host defence reaction has now entered this group. In
addition, the analysis has re-ordered the factors to a minor extent. Axillary node
metastases, clinical stage, and pathological size of primary still head the list.
There is considerable overlap between these three factors, but removal of this by
the analysis leaves each factor with a highly significant independent contribution
to survival. There is a positive correlation in Table 11 against
"radiotherapy
given "; this indicates that survival was pooreramongst thosegivenradiotherapy
as part ofthe initial treatment. Table III shows ahighlysignificantindependent
effect; this cannot beexplained thereforeby differences between those treated with
and without therapy for stage, malignancy, axillary node involvement, size of
tumour, or other recorded factors. Whether the surgeons had selected poor risk
patients forradiotherapy on account ofother more subtle and unrecorded reasons
cannot be demonstrated.
Two histological factors appear next in the list; the malignancy grading and
stromal reaction; these and the combined score for the five factors contributing to
host defence response each make an independent contribution to survival, that is
significant at the I% level. The factor
" site ofprimary
" isprobablyartificially
high in the list due to the method ofallocating scores to the individual sites within
the breast.
The importance of the quality of the fibrous stroma present in the tumour is
surprising. In an early paper (Hueper, 1932), the dense fibrous stroma present
in a scirrhous carcinoma was interpreted as a protective scarring and in that
analysis, the presence of this type of stroma did appear to be associated with a
marginally better prognosis. This may, of course, have had something to do
with the proportion of cases which were ofmalignancy grade I, since a large pro-
portion ofgrade I tumours do have a
" scirrhous
" stroma and of course Grade I
tumours have a 50% 15 year survival. In the present study where the analysis is taking cognisance of this fact, and the stroma ofthe tumours was divided into
essentially fibrovascular or essentially collagenous or
" scirrhous ", a statistically significant difference in prognosis is found, the better group containing those cases
having a fibrovascular stroma. This finding, although noted and discussed by Hamlin (1968) was not includedthen in the H.D.R. score, since there is no evidence
that this is an immunological reaction, although clearly it is a host response. Approximately equal numbers of clinical Stage III patients in this series died
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staging, though high on the list in Table 111, is unable to adequately identify a
discrete group. Using data for all the 21 individual prognostic factors, a pre-
diction score has been calculated and the patients arbitrarily divided into three
categories. The results given in Table IV indicated a closer association between
prediction score and survival than between clinical stage and survival. A predic-
tion score was also calculated from a limited set ofdata, without use ofinformation
from pathology of the axillary nodes. The results are presented in Table V; the
prediction is again much more closely associated with actual survival than is
clinical stage.
GENERAL DISCUSSION
The importance of clinical stage and axillary node metastases in the prognosis
ofcarcinoma ofthe breast has been confirmedby thisanalysis andalthoughclearly
related, each does have an independent contribution to make to the assessment of
prognosis. It is unfortunate that in the original analysis the proportion of
axillary nodes involved was not noted. Cutler et al. (1969) observed a positive
association between survival and the proportion of nodes involved.
The size of the primary in this work was the size of tumour measured by the
pathologist on the cut surface ofthe tumour and in thisanalysis a clearrelationship
toprognosis has been found. Clinical size oftumour is more difficult to assess and
there does not appear to be a clear relationship between clinical size and patho-
logical size. An attempt to analyse the factors involved in this discrepancy is at
present being made on this and another series ofpatients.
In this analysis the contribution made by the stromal reaction in the tumour
is apparently independent of other histological factors such as the malignancy of
the tumour, the shape of the tumour infiltration, and the lymphocytic and
plasmacyticinfiltration ofthe stroma. Nevertheless while thehistologicalanalysis
was being made it was observed that a dense lymphocytic and plasmacytic
infiltration was often associated with a loose fibrovascular stroma. Is it possible
that even in the absence of a visible cellular infiltration, circulating lymphocytes
have easier and more intimate contact with the tumour when the stroma is loose
and vascular and that the immunological defences are therefore more efficient in
these cases? The, variation in the density of the collagenous stroma does not
appear to be related to the size of the tumour, since a loose fibrovascular stroma
may be seen inlarge tumours and a densecollagenous stromainverysmalltumours.
The reason for the clearly poorer prognosis ofpatients receiving irradiation in
this series will remain a subject of debate. Depression of host immunological
defences in the crucial post-operative period, when carcinoma cells released into
the blood stream during operation are establishing themselves, is certainly a
possibility. What is clear from this analysis is thatprognosis in breast carcinoma
treated by radical mastectomy is not improved by post-operative irradiation.
Conflicting views have been expressed in the literature on the relationship of
site in breast toprognosis(Truscott, 1947; Smithers etal., 1952; Treves and Holleb,
1958) but generally it is accepted that inner quadrant tumours have a poorer
prognosis. Certainly in this series, patients with tumours in the upper outer
quadrant formed the largest group and also showed a high mean survival.
Thedegree ofdifferentiation of a tumour was firstrecognisedtobeofimportance
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based upon this histological feature. The findings in this analysis confirm the
independent contribution which themalignancy ofthe tumour makes toprognosis.
The relationship of the histological features interpreted by Hamlin (1968) as
an immunological host defence reaction to survival has been confirmed by this
analysis. It is clear that the different factors making up the host defence score
vary in importance and that the cellular infiltration in and around the tumour in
the breast has more influence on prognosis than the histological changes in the
axillary nodes (i.e. other than metastases). This has been taken into account in
designing the second predictive index (see below).
Ofthe factors which are notsignificant statistically, it is interesting to observe
in Table III that
" immunoblasts in the axillary nodes
" has a much higher figure
than
" plasma cell content ofaxillar nodes
" or
" germinal centres This would
be in agreement with the present view that effective host defence in carcinoma is
cellular rather than humoral.
The prediction scores, derived from this analysis, show a hopefully close
association with prognosis. However Armitage, McPherson and Copes (1969) in
discussing advanced breast cancer, point out that a method ofprediction is likely
to be less effective on subsequent data than it appears to be when applied retro-
spectively to the data from which it was derived. Obviously the weights calcu-
lated from the present series will have to be applied to a fresh set of material in
order to test the validity of the predictive instrument. This work is now in
progress.
If the predictive instrument is found effective when applied to a second fresh
collection ofretrospective patient data, it may be possible to use it prospectively
on data from individual patients immediately after operation as aguide to further
clinical management. The current surgical trend is away from radical surgery
and there may therefore be no material from the axilla for histological study.
The second prediction score has been calculated on such clinical and pathological
data as would be available after excision biopsy or simple mastectomy.
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